戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ns or seizures even in the absence of severe lymphocytopenia.
2 ents included seizure, pleural effusion, and lymphocytopenia.
3 d are absent in patients with idiopathic CD4 lymphocytopenia.
4 he need for an alternative mechanism for the lymphocytopenia.
5 n 7 in a patient with idiopathic CD4+ T-cell lymphocytopenia.
6 icient patients develop a severe progressive lymphocytopenia.
7 ected patients, which are characterized by T lymphocytopenia.
8 lase (PNP) deficiency in humans results in T lymphocytopenia.
9 of splenic CD4(+)CD8(-) cells and a systemic lymphocytopenia.
10  was not predicted by the severity of CD4+ T lymphocytopenia.
11     No association was found between HIV and lymphocytopenia.
12 s for assessing the development of transient lymphocytopenia.
13 penia were different to the 12 women without lymphocytopenia.
14 leads to spontaneous T cell activation and T lymphocytopenia.
15 21); and grade 3 or 4 thrombocytopenia (29), lymphocytopenia (18), and neutropenia (18).
16 he most common grade 3-4 adverse events were lymphocytopenia (19 [14%] of 131), skin rash (16 [12%]),
17 e frequent in the cladribine groups included lymphocytopenia (21.6% in the 3.5-mg group and 31.5% in
18                Neutropenia (0-29 cells/muL), lymphocytopenia (36-130 cells/muL), and thrombocytopenia
19 cluded elevated C-reactive protein (57%) and lymphocytopenia (50%).
20  during KCd induction and consolidation were lymphocytopenia (72 [26%] of 278 patients who started in
21 oxoplasmosis, including transaminitis (86%), lymphocytopenia (88%), thrombocytopenia (38%), and leuko
22  [8%]), and fatigue (ten [8%]) in part A and lymphocytopenia (96 [73%]), leukocytopenia (42 [32%]), t
23 rabine/cyclophosphamide led to more profound lymphocytopenia after tisagenlecleucel infusion compared
24 d alopecia, a condition we named enteropathy-lymphocytopenia-alopecia.
25                                       Severe lymphocytopenia and an extent of GGO >50% on chest CT we
26 g for severe combined immunodeficiency and T lymphocytopenia and broad genetic testing, including nex
27 everal immune-related complications, such as lymphocytopenia and cytokine storm, which are associated
28 ia-telangiectasia (A-T) syndrome with severe lymphocytopenia and greatly increased risk for T-cell ly
29       In the second family, 2 brothers had B lymphocytopenia and immunoglobulin deficiencies.
30 Rdelta locus as the molecular origin of both lymphocytopenia and the signature t(12;14) translocation
31                    Cancer type, neutropenia, lymphocytopenia, and hospital admission during acute COV
32 pendent risk factor for anemia, neutropenia, lymphocytopenia, and thrombocytopenia.
33 lting in more infants with SCID and severe T lymphocytopenia being detected each year.
34 P in patients with HC were male sex, anemia, lymphocytopenia, chronic kidney disease, cardiovascular
35 NF-alpha was significantly lower in gradable lymphocytopenia compared to non-lymphocytopenia women fo
36                                     Gradable lymphocytopenia compared to non-lymphocytopenia women ha
37  are a general surrogate marker for severe T lymphocytopenia, conditions other than SCID are also ide
38                Monocytopenia, B, NK, and CD4 lymphocytopenia correlated with the presence of disease
39 VD 18%) and likely related to a high rate of lymphocytopenia (CTC grade 3/4: DD 20%, DVD 17%).
40 ong hospitalized patients with hypoxemia and lymphocytopenia due to COVID-19.
41  of hospitalized patients with hypoxemia and lymphocytopenia due to COVID-19.
42  and 4 treatment-related adverse events were lymphocytopenia (eight [20%] of 40 patients), fatigue (e
43 standing factors that could amplify rates of lymphocytopenia, even if transient, remain undefined.
44 onsidered and extended to "SCID and severe T lymphocytopenia." Even though complete harmonization of
45                               Idiopathic CD4 lymphocytopenia (ICL) is a clinical syndrome that is def
46                       Idiopathic CD4+ T cell lymphocytopenia (ICL) is a heterogeneous syndrome presen
47                            Idiopathic CD4+ T lymphocytopenia (ICL) is a rare heterogeneous disorder d
48                            Idiopathic CD4(+) lymphocytopenia (ICL) is a rare non-HIV-related syndrome
49 tion of microbial products in idiopathic CD4 lymphocytopenia (ICL), a rare disorder characterized by
50 this syndrome, a subset of idiopathic CD4+ T lymphocytopenia (ICL), is uncertain.
51 on of lymphocytes in white pulp and a marked lymphocytopenia in 15 of 19 patients.
52 nemia in 22% of patients, leukopenia in 13%, lymphocytopenia in 24%, and thrombocytopenia in 17%.
53            Adverse events included transient lymphocytopenia in eight (19%), proteinuria in nine (21%
54       Mutations in XLF/Cernunnos (XLF) cause lymphocytopenia in humans, and various studies suggest a
55           The repeated induction of profound lymphocytopenia in patients undergoing multiple cycles o
56  RAG chimeric mice exhibited profound T cell lymphocytopenia in the peripheral circulation.
57 sponse, underlies the progressive and severe lymphocytopenia in XLF-deficient patients in the absence
58                                       Severe lymphocytopenia (less than 300/microL) at the time of fi
59                                        CD8 T lymphocytopenia (< 180/mm(3)) and the degree of CD4 T ce
60 a consideration in patients with significant lymphocytopenia (<0.5 x 10(9) cells/L).
61 , who had developed severe and long-standing lymphocytopenia (<500/mm(3) ).
62 ells/microL; median, 4 cells/microL), and NK lymphocytopenia (mean, 16 cells/microL; median, 5.5 cell
63  cells/microL; median, 14.5 cells/microL), B lymphocytopenia (mean, 9.4 cells/microL; median, 4 cells
64 nged with CHAPV had progressive weight loss, lymphocytopenia, neutropenia, thrombocytopenia, hepatiti
65                             Acute, transient lymphocytopenia, not clinically significant was observed
66                   ATM(-/-) mice recapitulate lymphocytopenia of A-T patients and routinely succumb to
67 eficient mice recapitulate the age-dependent lymphocytopenia of patients.
68 d of having miliary tuberculosis with severe lymphocytopenia or an extent of ground glass opacity (GG
69 herapy is warranted for patients with severe lymphocytopenia or positive blood PCR, and in those in w
70 most common grade 3 or 4 adverse events were lymphocytopenia (seven [19%] patients with grade 3 and t
71 examined using the key words: burn patients, lymphocytopenia, skin oxidative stress, antioxidant, mel
72 leoside phosphorylase (PNP) deficiency and T lymphocytopenia suggested that inhibition of this enzyme
73  lower prior to bnAbs in women with gradable lymphocytopenia than those without.
74 cy (SCID), XLF mutations cause a progressive lymphocytopenia that is generally less severe than SCID.
75                                              Lymphocytopenia was assigned upon a > 50% decline in abs
76  88 (56%), dyspnea was observed in 52 (33%), lymphocytopenia was observed in 95 (60%), increased C-re
77 tokine profiles of eight women who developed lymphocytopenia were different to the 12 women without l
78 ukoencephalopathy and idiopathic CD4+ T-cell lymphocytopenia were established, a 61-year-old man was
79                   They have CD4+ alphabeta T lymphocytopenia with a concomitant expansion of CD4-CD8-
80 l patients displayed a profound, generalized lymphocytopenia, with few lymphocytes present in the lym
81  in gradable lymphocytopenia compared to non-lymphocytopenia women for enrolment, days 7, 28 and 56 e
82     Gradable lymphocytopenia compared to non-lymphocytopenia women had significantly higher MIP-1beta
83            Additionally, within the gradable lymphocytopenia women, 9 additional cytokines (TNF-alpha
84       Within the gradable and within the non-lymphocytopenia women, from enrolment to day 1, signific